AAV Manufacturing
ProBio Launches GMP AAV Manufacturing Services at Hopewell Facility to Advance Gene Therapy Development and Manufacturing
ProBio Inc
PR-08-25-NI-01Aug 11, 2025
In VIvo CAR-T
In Vivo CAR-T Technology Poised to Expand Access and Indications
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-25-NI-07Aug 11, 2025
Gene Therapy
Gene Therapy at a Crossroads: What the Sarepta Crisis Reveals — and What Comes Next
David Alvaro, Ph.D.; April Stanley, MS MBA; Sophie Lutter, Ph.D.
Pharma's Almanac
PAO-08-25-NI-02Aug 05, 2025
Viral Vectors
De-Risking Cell and Gene Therapies with Innovative Solutions: A Review for Leveraging a Proven Workhorse Technology in New Ways
Farzin Farzaneh, Ph.D.; Nicholas Ostrout, Ph.D.; Glenda Dickson, Ph.D.; David Darling, Ph.D.
ViroCell Biologics
PAO-06-25-CL-12Jul 31, 2025
ssDNA
Leveraging the Therapeutic Potential of Single-Stranded DNA
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-07-25-NI-10Jul 23, 2025
Viral Vectors
Backbone of Innovation: How CDMO Vector Platforms Are Accelerating Gene Therapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-09Jul 21, 2025
Exosomes
Exosomes: A Promising Natural Nanoparticle Delivery System
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-07-25-NI-04Jul 14, 2025
Exosomes
Five Exosome Biotechs to Watch: July 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-01Jul 01, 2025
Biomanufacturing
What are the most significant manufacturing hurdles in biopharma and how can they be addressed?
Pharma's Almanac
PAO-06-25-RT-02Jun 30, 2025
CGT
ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility to Advance Cell and Gene Therapy
ProBio Inc
PR-06-25-NI-11Jun 30, 2025
Viral Vector CDMOs
Breaking Through the Noise in Viral Vector CDMO Marketing
Emilee Kudla
Pharma's Almanac
PAO-06-25-NI-10Jun 25, 2025
Gene Editing
What are the key ethical and regulatory considerations as gene editing technologies advance toward widespread clinical use?
Pharma's Almanac
PAO-05-25-RT-02Jun 17, 2025
Exosomes
Nature’s Nanocarriers: The Evolving Role of Exosomes in Targeted Drug Delivery
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-04May 13, 2025
AAV
Gene Therapy at a Crossroads: Rethinking AAV Amid Industry Resets
Daniel Smith, Ph.D.
Nice Consulting
PAO-05-25-NI-02May 06, 2025
Xenotransplantation
CRISPR-Edited Pig Organs and the Promise of Xenotransplantation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-13Apr 25, 2025
Oncology
From Chemo to Advanced Therapies: New Frontiers in Oncology
Serene Lee
Nice Insight
PAO-25-30-29Apr 15, 2025
Gene Therapy
Gene Therapy at 30: Milestones, Setbacks, and a Path Forward
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-25-30-28Apr 14, 2025
Cell Therapy
Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights
April Stanley, MS MBA; Sophie Lutter, Ph.D.
Nice Insight
PAO-03-25-NI-07Mar 26, 2025
OMVs and EVs
Driving Therapeutic Innovation with OMVs and EVs
Ola Tuvesson; Isa Lindgren, Ph.D.
NorthX Biologics
PAO-02-25-CL-09Mar 21, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24Mar 21, 2025